EU Transdermal Patch: Generic Submission [Design Issues]

posted by HallaGulla – 2023-03-08 09:58 (406 d 15:11 ago) – Posting: # 23491
Views: 1,003

(edited by on 2023-03-08 11:11)

Hi All

One of the clients with whom I am working is developing a generic transdermal patch for UK/EU submission.

They are asking us to do the PK study, Adhesion study and skin senstization study in either EU/UK or in USA due to simialr climatic condition.

My question is, can these studies be done in India or any other countries? Does MHRA/EMA accepts transdermal studies done in the geographies which has a different climatic conditions?


TIA...


Edit: Category changed; see also this post #1. Are you really located in Japan? ;-) [Helmut]

:lol: Shhhhh

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,656 registered users;
51 visitors (0 registered, 51 guests [including 6 identified bots]).
Forum time: 02:10 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5